For the treatment of advanced non-small-cell lung cancer, randomized controlled trials have shown that platinum-based chemotherapy and radiotherapy provide a measurable survival benefit compared with radiotherapy alone. Newer drugs that target growth factor receptors might further synergize with ionizing irradiation, although convincing data from multicenter phase III are currently lacking. The authors discuss why concurrent chemoradiation followed by consolidation platinum-based chemotherapy is an attractive approach for treating patients with inoperable tumors.
- Wilfried Eberhardt
- Christoph Pöttgen
- Martin Stuschke